Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Edema Secondary to Retinal Vein Occlusion”

73 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 73 results

Testing effectiveness (Phase 2)Study completedNCT04667910
What this trial is testing

601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Post-approval studies (Phase 4)Study completedNCT02953938
What this trial is testing

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
Novartis Pharmaceuticals 59
Large-scale testing (Phase 3)Study completedNCT03223714
What this trial is testing

Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion

Who this might be right for
Macular EdemaCentral Retinal Vein Occlusion
Chengdu Kanghong Biotech Co., Ltd. 242
Not applicableUnknownNCT01581151
What this trial is testing

Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Brian Burke, MPH 30
Not applicableStudy completedNCT04812977
What this trial is testing

Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein Occlusion

Who this might be right for
Central Retinal Vein Occlusion With Macular Edema
Hayatabad Medical Complex 30
Large-scale testing (Phase 3)Study completedNCT00485836
What this trial is testing

The Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Genentech, Inc. 392
Large-scale testing (Phase 3)UnknownNCT04460001
What this trial is testing

Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)

Who this might be right for
Ophthalmopathy
Assiut University 100
Not applicableStudy completedNCT05345808
What this trial is testing

Efficacy of Formulated Posterior Sub Tenon Triamcinolone in Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusions

Who this might be right for
Retinal Vein Occlusion
Al-Azhar University 46
Post-approval studies (Phase 4)UnknownNCT03405376
What this trial is testing

Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion With Macular Edema
Yeungnam University College of Medicine 49
Not applicableStudy completedNCT01614509
What this trial is testing

Combined Therapy of Posterior Subtenon Triamcinolone Acetonide and Intravitreal Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Yeungnam University College of Medicine 45
Large-scale testing (Phase 3)Study completedNCT01969708
What this trial is testing

Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2)

Who this might be right for
Central Retinal Vein Occlusion
The Emmes Company, LLC 362
Testing effectiveness (Phase 2)UnknownNCT05290948
What this trial is testing

Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions

Who this might be right for
Macular Edema
Shahid Beheshti University of Medical Sciences 57
Testing effectiveness (Phase 2)Study completedNCT04667897
What this trial is testing

601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Branch Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Testing effectiveness (Phase 2)Ended earlyNCT00770770
What this trial is testing

Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Alimera Sciences 20
Testing effectiveness (Phase 2)UnknownNCT01809236
What this trial is testing

Efficacy and Safety of Conbercept in Macular Edema Secondary to Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Chengdu Kanghong Biotech Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT01976338
What this trial is testing

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion
Novartis Pharmaceuticals 283
Large-scale testing (Phase 3)Study completedNCT02698566
What this trial is testing

A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)

Who this might be right for
Macular Edema
Genentech, Inc. 35
Not applicableStudy completedNCT03054766
What this trial is testing

Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for ME Secondary to BRVO

Who this might be right for
Branch Retinal Vein OcclusionRanibizumabLaser Photocoagulation
Beijing Hospital 80
Not applicableStudy completedNCT01442064
What this trial is testing

An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Genentech, Inc. 608
Testing effectiveness (Phase 2)Study completedNCT07550504
What this trial is testing

Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, or mCNV

Who this might be right for
Age-Related Macular DegenerationBranch Retinal Vein Occlusion With Macular EdemaCentral Retinal Vein Occlusion With Macular Edema+1 more
Samsung Bioepis Co., Ltd. 30
Load More Results